Eric Marsh, MD, PhD
Dr. Marsh received his MD, PhD from New York University (NYU) School of Medicine, with his studies focusing on the neural basis of adaptation in the occulomotor reflex circuit.
After graduating NYU, he completed his pediatric residency at Bellevue Hospital before moving to Philadelphia and the Children's Hospital of Philadelphia (CHOP) for a child neurology fellowship. He completed a two-year epilepsy clinical and research fellowship at CHOP funded by grants from the American Epilepsy Society and Epilepsy Foundation. He then completed post-doctoral fellowship research under the guidance of Drs. Jeff Golden and Amy Brooks-Kayal. During this time, he began his studies on the effect of Arx mutations on the physiology of the developing and mature cortex. With funding for this work, he became an assistant, then associate professor at the University of Pennsylvania Perelman School of Medicine and CHOP. His lab focuses primarily on understanding how developmental disorders lead to the early epileptic encephalopathies, using Arx mice as models of these conditions.
Recently, he has been performing clinical studies on the safety and efficacy of cannabidiol in Dravet syndrome and other early-onset severe epilepsy. Clinically, Dr. Marsh’s focus and clinical research is the clinical features and genetics of the early epileptic encephalopathies and brain malformations. He directs the Neurogenetics Clinic at CHOP.